HK1140700A1 - Compositions and methods for modulating endophthalmitis using fluoroquinolones - Google Patents

Compositions and methods for modulating endophthalmitis using fluoroquinolones

Info

Publication number
HK1140700A1
HK1140700A1 HK10107282.0A HK10107282A HK1140700A1 HK 1140700 A1 HK1140700 A1 HK 1140700A1 HK 10107282 A HK10107282 A HK 10107282A HK 1140700 A1 HK1140700 A1 HK 1140700A1
Authority
HK
Hong Kong
Prior art keywords
fluoroquinolones
compositions
methods
endophthalmitis
modulating
Prior art date
Application number
HK10107282.0A
Other languages
English (en)
Inventor
Keith Wayne Ward
Jinzhong Zhang
Matthew Scott Jonasse
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of HK1140700A1 publication Critical patent/HK1140700A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK10107282.0A 2007-08-21 2010-07-29 Compositions and methods for modulating endophthalmitis using fluoroquinolones HK1140700A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95700507P 2007-08-21 2007-08-21
PCT/US2008/072552 WO2009026009A1 (en) 2007-08-21 2008-08-08 Compositions and methods for modulating endophthalmitis using fluoroquinolones

Publications (1)

Publication Number Publication Date
HK1140700A1 true HK1140700A1 (en) 2010-10-22

Family

ID=39886006

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10107282.0A HK1140700A1 (en) 2007-08-21 2010-07-29 Compositions and methods for modulating endophthalmitis using fluoroquinolones

Country Status (13)

Country Link
US (1) US20090054406A1 (ko)
EP (1) EP2178535B1 (ko)
JP (1) JP2010536860A (ko)
KR (1) KR101227230B1 (ko)
CN (1) CN101784275A (ko)
AU (1) AU2008289347B2 (ko)
BR (1) BRPI0815599A2 (ko)
CA (1) CA2696613C (ko)
ES (1) ES2392208T3 (ko)
HK (1) HK1140700A1 (ko)
MX (1) MX2010001841A (ko)
TW (1) TW200918075A (ko)
WO (1) WO2009026009A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102422068A (zh) 2009-03-11 2012-04-18 迪普弗莱克斯有限公司 用于修补挠性纤维增强管子的方法和设备
WO2018144909A1 (en) * 2017-02-03 2018-08-09 The Administrators Of The Tulane Educational Fund Ophthalmic compositions for therapeutic and prophylactic uses
JP7289538B2 (ja) 2018-03-12 2023-06-12 国立大学法人高知大学 新規バクテリオファージおよび細菌性眼内炎治療剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US6699492B2 (en) * 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
AU2002247284A1 (en) * 2001-04-02 2002-10-15 Alcon, Inc. Method of treating ocular inflammatory and angiogenesis-related disorders using an amide derivative of flubiprofen or ketorolac
WO2004097410A1 (en) * 2003-04-30 2004-11-11 Pfizer Products Inc. Screening methods for cataractogenic risk
US7632944B2 (en) * 2007-01-24 2009-12-15 Bausch & Lomb Incorporated Quinolone carboxylic acids, derivatives thereof, and methods of making and using same
EP2136812B1 (en) * 2007-03-21 2013-09-04 Bausch & Lomb Incorporated Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria

Also Published As

Publication number Publication date
CA2696613C (en) 2012-09-18
KR20100034049A (ko) 2010-03-31
MX2010001841A (es) 2010-03-10
JP2010536860A (ja) 2010-12-02
KR101227230B1 (ko) 2013-01-28
US20090054406A1 (en) 2009-02-26
WO2009026009A1 (en) 2009-02-26
ES2392208T3 (es) 2012-12-05
EP2178535B1 (en) 2012-09-19
AU2008289347B2 (en) 2011-12-08
AU2008289347A1 (en) 2009-02-26
TW200918075A (en) 2009-05-01
BRPI0815599A2 (pt) 2015-03-03
CA2696613A1 (en) 2009-02-26
EP2178535A1 (en) 2010-04-28
CN101784275A (zh) 2010-07-21

Similar Documents

Publication Publication Date Title
ZA201003084B (en) Compositions and methods for enhancing cognitive function
HK1200485A1 (en) Methods and compositions for facilitating regeneration
EG25577A (en) Procedures and compositions for reservoir protection
EP2435057A4 (en) COMPOSITIONS AND METHODS FOR MODULATING THE LIPID COMPOSITION
ZA201001300B (en) Antigen-asjuvant compositions and methods
EP2310507A4 (en) METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
ZA200908481B (en) Compositions and methods for altering gene expression
ZA201006944B (en) Compositions and methods for preparing and using same
HK1137670A1 (en) Compositions and methods for arthrodetic procedures
EP2129680A4 (en) COMBINED HAIR-ANTISENSE HAIR LOOP COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION
PL2150282T3 (pl) Kompozycje i sposoby tworzenia rusztowania
EP2194783A4 (en) COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS
EP2152247A4 (en) COMPOSITIONS AND METHODS ANTI-INSOMNIA
GB0721291D0 (en) Methods and compositions
EP2235033A4 (en) METHOD AND COMPOSITIONS FOR INCREASING GENE EXPRESSION
IL205248A0 (en) Compositions and methods for making androstenediones
EP2015782A4 (en) COMPOSITIONS AND METHODS FOR MODULATING GENE EXPRESSION
EP2205271A4 (en) COMPOSITIONS AND METHODS OF THERAPIES BASED ON RIBONUCLEASE BASE
EP2313516A4 (en) COMPOSITIONS AND METHODS FOR MODULATING THE NOD LIKE RECEPTOR ACTIVITY AND THEIR USE
GB0719526D0 (en) Compositions and methods
EP2150818A4 (en) COMPOSITIONS AND METHOD FOR COMBINING REPORT ANTIBODIES
EP2278984A4 (en) COMPOSITIONS AND METHODS FOR ENHANCING FERTILITY
HK1140700A1 (en) Compositions and methods for modulating endophthalmitis using fluoroquinolones
HK1141682A1 (en) New compositions and methods for cell killing

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160808